NIH: The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trial Required)
This FOA,issued by The National Cancer Institute (NCI), continues support for the Experimental Therapeutics Clinical Trials Network (ETCTN) for the efficient and comprehensive conduct of early phase clinical trials of NCI Investigational New Drug (IND) agents.
USC may only submit only one application in response to this program announcement. Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send a two page abstract via email to Richard White (email@example.com) by April 12, 2019. In addition to the 2-page abstract, you should also submit a biosketch for the PI.
NIH indicates that a letter of intent is NOT required and a completed application is due by May 22, 2019. For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-007.html#_3._Additional_Information